medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2024, Number 2

<< Back Next >>

Rev Mex Anest 2024; 47 (2)

COVID-19: its implications for the practice of pain medicine

Covarrubias-Gómez A, Vargas-Bermúdez A, Pérez-Franco E, López-Collada-Estrada M, Carrillo-Torres O, V SN, Báez-Báez JU, Arboleda-Castro MF, Gutiérrez-Salmerón C, Esquer-Guzmán HM

Language: Spanish
References: 32
Page: 108-112
PDF size: 279.98 Kb.


ABSTRACT

Introduction: COVID-19 has caused many deaths on the planet. To date we do not know its long-term impact. Conversion of hospital centers and home reclusion impacted those with a disease. Currently, the presence of pain has been identified as a chronic complication of COVID-19. Objective: to document the impact of COVID-19 on patients with pain and its chronicity. Material and methods: literature search in the PubMed database for documents that contained the words "COVID", "SARS-CoV", "Pain" in the title. No meta-analyses were identified. We found systematized and documentary reviews on which we based our information. Conclusions: COVID-19 presents chronic pain as a long-term manifestation. It is advisable to generate lines of research aimed at documenting this phenomenon.


REFERENCES

  1. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215:108427. doi: 10.1016/j.clim.2020.108427.

  2. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953?1966. doi: 10.1056/NEJMoa030781.

  3. Covid-19 Data Explorer. Our World in Data. Global Change Data Lab. 2022. Recuperado el 29 de Agosto de 2022 del enlace en internet. Available in: https://ourworldindata.org/explorers/coronavirus-data-explorer

  4. Departamento de Comunicación Social. Características de las Defunciones Registradas En México. Comunicado De Prensa Núm. 24/22. Instituto Nacional De Estadística, Geografía e Informática. 2022. [Recuperado el 29 de Agosto de 2022 el enlace en internet] Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2022/dr/dr2021.pdf

  5. Covarrubias-Gómez A, Salinas-Palacios CK, Arriaga-Morales E, et al. Recomendaciones para la sedoanalgesia del enfermo infectado con SARS-CoV-2 en ventilación mecánica. Rev Mex Anest. 2020;43:251-256. doi: 10.35366/94937.

  6. Papalia GF, Petrucci G, Russo F, et al. COVID-19 pandemic increases the impact of low back pain: a systematic review and metanalysis. Int J Environ Res Public Health. 2022;19:4599. doi: 10.3390/ijerph19084599.

  7. Shanthanna H, Nelson AM, Kissoon N, Narouze S. The COVID-19 pandemic and its consequences for chronic pain: a narrative review. Anaesthesia. 2022;77:1039-1050. doi: 10.1111/anae.15801.

  8. Deer TR, Sayed D, Pope JE, et al. Emergence from the COVID-19 pandemic and the care of chronic pain: guidance for the interventionalist. Anesth Analg. 2020;131:387-394. doi: 10.1213/ANE.0000000000005000.

  9. Malik GR, Wolfe AR, Soriano R, et al. Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth. 2020;125:e478-e480. doi: 10.1016/j.bja.2020.08.045.

  10. Clauw DJ, Hauser W, Cohen SP, Fitzcharles MA. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161:1694-1697. doi: 10.1097/j.pain.0000000000001950.

  11. Javed S, Hung J, Huh BK. Impact of COVID-19 on chronic pain patients: a pain physician's perspective. Pain Manag. 2020;10:275-277. doi: 10.2217/pmt-2020-0035.

  12. Karos K, McParland JL, Bunzli S, et al. The social threats of COVID-19 for people with chronic pain. Pain. 2020;161:2229-2235. doi: 10.1097/j.pain.0000000000002004.

  13. Zhu J, Ji P, Pang J, Zhong Z, et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol. 2020;92:1902-1914. doi: 10.1002/jmv.25884.

  14. Fan CK, Yieh KM, Peng MY, Lin JC, Wang NC, Chang FY. Clinical and laboratory features in the early stage of severe acute respiratory syndrome. J Microbiol Immunol Infect. 2006;39:45-53.

  15. Wang JT, Sheng WH, Fang CT, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10:818-824. doi: 10.3201/eid1005.030640.

  16. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. J Infect. 2020;80:607-613. doi: 10.1016/j.jinf.2020.03.037.

  17. De Heer EW, Gerrits MM, Beekman AT, et al. The association of depression and anxiety with pain: a study from NESDA. PLoS One. 2014;9:e106907. doi: 10.1371/journal.pone.0106907.

  18. Ao G, Li A, Wang Y, Li J, Tran C, Chen M, Qi X. Opioid usage and COVID-19 prognosis: A systematic review and meta-analysis. Am J Emerg Med. 2022;56:51-56. doi: 10.1016/j.ajem.2022.03.048.

  19. Ghose R, Forati AM, Mantsch JR. Impact of the COVID-19 pandemic on opioid overdose deaths: a spatiotemporal analysis. J Urban Health. 2022;99:316-327. doi: 10.1007/s11524-022-00610-0.

  20. Macmadu A, Batthala S, Correia Gabel AM, et al. Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in rhode island. JAMA Netw Open. 2021;4:e2125538. doi: 10.1001/jamanetworkopen.2021.25538.

  21. Zhu J, Zhong Z, Ji P, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health. 2020;8:e000406. doi: 10.1136/fmch-2020-000406.

  22. Caronna E, Ballvé A, Llauradó A, et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410-1421. doi: 10.1177/0333102420965157.

  23. Puntillo F, Giglio M, Brienza N, et al. Impact of COVID-19 pandemic on chronic pain management: looking for the best way to deliver care. Best Pract Res Clin Anaesthesiol. 2020;34:529-537. doi: 10.1016/j.bpa.2020.07.001.

  24. Cascella M, Del Gaudio A, Vittori A, et al. COVID-pain: acute and late-onset painful clinical manifestations in COVID-19-molecular mechanisms and research perspectives. J Pain Res. 2021;14:2403-2412. doi: 10.2147/JPR.S313978.

  25. Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268:3059-3071. doi: 10.1007/s00415-021-10406-y.

  26. Marinangeli F, Giarratano A, Petrini F. Chronic pain and COVID-19: pathophysiological, clinical and organizational issues. Minerva Anestesiol. 2021;87:828-832. doi: 10.23736/S0375-9393.20.15029-6.

  27. Carfì A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603-605. doi: 10.1001/jama.2020.12603.

  28. Sykes DL, Holdsworth L, Jawad N, et al. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113-119. doi: 10.1007/s00408-021-00423-z.

  29. Illés R, Chochol J, Džubera A, Chocholová A, Zemková E. COVID-19 worsens chronic lumbosacral radicular pain-case series report. Int J Environ Res Public Health. 2022;19:6410. doi: 10.3390/ijerph19116410.

  30. Covarrubias-Gómez A, Guevara-López UM, Cantú-Brito C, Nuche-Cabrera E, Guajardo-Rosas JA. Recomendaciones de práctica clínica para el manejo del dolor neuropático: grupo de interés en dolor neuropático de la Asociación Mexicana para el Estudio y Tratamiento del Dolor. Rev Mex Anest. 2015;38:264-276.

  31. Joshi D, Gyanpuri V, Pathak A, et al. Neuropathic pain associated with COVID-19: a systematic review of case reports. Curr Pain Headache Rep. 2022;22:1-9. doi: 10.1007/s11916-022-01065-3.

  32. Oaklander A, Mills A, Kelley M, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroinmunol Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.




2020     |     www.medigraphic.com